Analyst Ratings for Halozyme Therapeutics (HALO) [Buys]
HALO Rating Summary
HALO Price Target Summary
- Highest: $14.00 (Roth Capital)
- Lowest: $3.00 (Jefferies)
- Average: $9.38
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.38 (+17.8%)
Avg. $ Target:
$9.38 (+17.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2013 | Piper Jaffray | New Coverage | Overweight (N/A) |
10.00 (N/A) |
6.71 | 7.96 | 18.63% | Details |
| 1/14/2013 | BMO Capital | Upgrade | Outperform (Market Perform) |
12.00 (4.00) |
7.21 | 7.96 | 10.4% | Details |
| 3/8/2012 | Barclays » Updated 9/24/2012 |
New Coverage | Overweight (N/A) |
10.00 (8.00) |
11.19 | 7.96 | -28.87% | Details |
| 10/18/2011 | JMP Securities | Upgrade | Market Outperform (N/A) |
9.00 (N/A) |
7.39 | 7.96 | 7.71% | Details |
| 8/11/2011 | Roth Capital | New Coverage | Buy (N/A) |
14.00 (N/A) |
6.02 | 7.96 | 32.23% | Details |
| 4/1/2011 | Stifel Nicolaus | New Coverage | Buy (N/A) |
N/A (N/A) |
6.71 | 7.96 | 18.63% | Details |
